4//SEC Filing
Friedland Jeffrey 4
Accession 0001214659-19-007389
CIK 0001625288other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 2:07 PM ET
Size
7.3 KB
Accession
0001214659-19-007389
Insider Transaction Report
Form 4
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
- Gift
Common Stock
2019-11-22−228,800→ 0 total(indirect: By LLC) - Gift
Common Stock
2019-11-22−833,333→ 0 total
Holdings
- 19,000,000(indirect: By Kanativa USA Inc.)
Common Stock
Footnotes (1)
- [F1]The Reporting Person disclaims all beneficial ownership of the securities owned by Kanativa USA Inc., and this report shall not be deemed an admission of beneficial ownership of such securities by the Reporting Person.
Documents
Issuer
NEXIEN BIOPHARMA, INC.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001579962
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 2:07 PM ET
- Size
- 7.3 KB